The Small Molecule BC-2059 Inhibits Wingless/Integrated (Wnt)-Dependent Gene Transcription in Cancer through Disruption of the Transducin β-Like 1-β-Catenin Protein ComplexRaffaella Soldi, Sunil Sharma, Mohan R. Kaadige et al.|Journal of Pharmacology and Experimental Therapeutics|2021Cited by 15
Abstract 524: SP-3164, a novel ikaros and aiolos molecular glue degrader with preclinical activity in non-Hodgkin lymphomasDaniela Y. Santiesteban, Swaminathan P. Iyer, Aundrietta D. Duncan et al.|Cancer Research|2023Cited by 1
P1241: A NOVEL CEREBLON-BINDING MOLECULAR GLUE, SP-3164, SHOWS PRECLINICAL ACTIVITY IN NON-HODGKIN LYMPHOMASDaniela Y. Santiesteban, Swaminathan P. Iyer, Aundrietta D. Duncan et al.|HemaSphere|2023Cited by 0
Abstract B135: Activity of Tegavivint in Hepatocellular Carcinoma with Aberrant Wnt/β-catenin Signaling and Evaluation of Biomarker ResponseCiara Curran, Thomas G. Bird, Toshiyasu Suzuki et al.|Molecular Cancer Therapeutics|2025Cited by 0
Abstract 3900: Tegavivint, a first-in-class TBL1 inhibitor demonstrates potent activity in WNT-driven colorectal cancers.Raffaella Soldi, Sunil Sharma, Tithi Ghosh Halder et al.|Cancer Research|2026Cited by 0